Date updated:06-11-2008
These are stocks that I currently like to track and will potentially be buying as well. I won't list reasons that I do or don't like them (with the exception of the ones already written at my main portfolio) because it would take way too long for me to do. But it does give an idea of what I'm looking at throughout the market. Mostly large caps with a mix of smaller and more speculative names.
6/11: Added CG, Dropped CIT
12/4: Added EMC, Dropped GSF
11/1: Added ARII, dropped JOE
10/11: Added BA, dropped SPG
10/10: Don't usually give updates on individual names, but I found the development with AA to be very interesting. Note that I don't own any names on this list. That could change any time, but considering my stance of late I highly, highly doubt it will. Screwed up by dropping GS but you can keep the rest of the brokers.
9/5: Added ED, dropped DUK
8/15: Added MKL, LUK, JCI, WFC. Deleted GS, MS, CFC, COF. As far as I'm concerned, it's not too late to sell the brokers.
6/27: Added AMGN, deleted DOW
5/12: CVC got the bid, not sure if a better offer will come from an outside bidder. If you own it, probably not a bad idea to take some profits.
5/2: Wow, that was quick. CVC may be taken private by the Dolans at $36 or so. Still could fetch more from another bidder but maybe the third time is a charm.
4/30: Cannot actually add more names but am keeping an eye on CVC and EWY as well.
4/26: Added GD and HAL, replacing IP and AMAT

-
AXP
American Express - $39.72
- +0.05%
- $39.94
No Analysis added

-
NYX
Nyse Euronext Com - $28.39
- -0.80%
- $28.62
No Analysis added

-
AIG
American Internat - $36.24
- +10.59%
- $33.90
No Analysis added

-
SBUX
Starbucks Corpora - $24.23
- +2.58%
- $23.56
No Analysis added

-
GOOG
Google Inc. - $576.45
- +2.90%
- $563.75
No Analysis added

-
GOOG
Google Inc. - $576.45
- +2.90%
- $563.75
No Analysis added

-
PG
Procter & Gamble - $63.01
- -0.46%
- $63.23
No Analysis added

-
T
At&t Inc. - $25.52
- -0.16%
- $25.62
No Analysis added
- Scoops716 Watch List's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Calamos Advisors
- 3. Fidelity Select Pharma...
- 4. ProFunds Pharmaceutica...
- 5. BlackRock Health Scien...
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on March 11, 2010 The S&P 500 refuses to back down from its rally after posting gains in eight of the last 10 trading days. That’s a colossa...
By Roberto Pedone Posted on March 11, 2010 According to CNBC’s “Fast Money” traders, M&A activity is what will likely be the big driver going forward for the stoc...
By Jonas Elmerraji Posted on March 10, 2010, at 10:44 a.m. If there’s one industry that traders like to target, it’s the pharmaceutical indsutry. After all, pharma ...
By Jonas Elmerraji Posted on March 9, 2010 Stock futures look set to take a pause on Tuesday, following a sizable rally that pushed the S&P 500 from just above 1100 all...
A. On a non-GAAP basis, consolidated gross
margin was a 64.2% of revenue this
quarter, in line with the forecast we
provided at the end of the second
quarter. This was about three percentage
points lower than Q2—which we stated
was unsustainably high. The decline to a
more sustainable level this quarter was
due to the return to more typical
product margins and a modestly lower
contribution from deferred elements
coming off of the balance sheet. These
deferred revenue elements carry a very
high margin.
As expected, non-GAAP product gross
margin was also down just over three
percentage points sequentially to 59.8%.
We did not expect last quarter’s
unusually favorable configuration mix to
continue into Q3, and we passed along
cost savings to customers during the
quarter in order to stimulate share
gains.
We outta talk Moore's Law in relation
here.
Relation to manufacturing costs
As the cost of computer power to the
consumer falls, the cost for producers
to fulfill Moore's law follows an
opposite trend: R&D, manufacturing,
and test costs have increased steadily
with each new generation of chips.
Rising manufacturing costs are an
important consideration for the
sustaining of Moore's law.[32] This had
led to the formulation of "Moore's
second law", which is that the
capital cost of a semiconductor fab also
increases exponentially over time.
Materials required for advancing
technology (e.g., photoresists and other
polymers and industrial chemicals) are
derived from natural resources such as
petroleum and so are affected by the
cost and supply of these resources.
Nevertheless, photoresist costs are
coming down through more efficient
delivery, though shortage risks
remain."
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are the 10 stocks in the Dow Jones Industrial Average with the highest yields as of the market close on Mar. 8, 2009. more
Here are some stocks that moved up on unusual volume on Mar. 11, 2010. more
Here is a list of some of the biggest stocks that hit 52-week lows on Mar. 11, 2010. more













Comments not available